A Dose Escalating Study of HC002 in Healthy Adult Volunteers

"Part 1 will enroll 32 participants across 4 cohorts.~Route of administration: Oral Dose interval and frequency: Single oral dose range across 4 cohorts."

"Part 2 will enroll 24 participants across 3 cohorts.~Route of administration: Oral Dose interval and frequency: Once daily for 7 days"

Matching placebo will be administered across SAD and MAD